Quantitative proteomics identifies surfactant-resistant α-synuclein in cerebral cortex of Parkinsonism-dementia complex of Guam but not Alzheimer's disease or progressive supranuclear palsy

American Journal of Pathology

Volumn 171, Issue 3, 2007, Pages 993-1002

  Yang, Wan ^a   Woltjer, Randall L ^a   Sokal, Izabela ^a   Pan, Catherine ^a   Wang, Yan ^a   Brodey, Mary ^b   Peskind, Elaine R ^a   Leverenz, James B ^a   Zhang, Jing ^a   Perl, Daniel P ^c   Galasko, Douglas R ^d   Montine, Thomas J ^a,e  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Biosource Division   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; APOLIPOPROTEIN E;

AGED; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DEMENTIA; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FRONTAL CORTEX; GUAM; HUMAN; HUMAN TISSUE; LEWY BODY; MALE; NEUROPATHOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEOMICS; QUANTITATIVE ANALYSIS; TEMPORAL CORTEX;

EID: 34548845831     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2007.070015     Document Type: Article

References (58)

1. Zimmerman HM: Monthly Report to Medical Officer in Command, U.S. Naval Medical Research Unit No. 2. Guam, Micronesian Area Research Center, 1945
2. Kurland LT, Mulder DW: Epidemiologic investigations of amyotrophic lateral sclerosis. I. Preliminary report on geographic distribution and special reference to the Mariana Islands, including clinical and pathologic observations. Neurology 1954, 4:438-448
3. Hirano A, Kurland LT, Krooth RS, Lesseil S: Parkinsonism-dementia complex, an endemic disease on the island of Guam. I. Clinical features. Brain 1961, 84:642-661
4. Hirano A, Malamud N, Kurland LT: Parkinsonism-dementia complex, an endemic disease on the island of Guam. II. Pathological features. Brain 1961, 84:662-679
5. Kurland LT, Mulder DW, Sayre GP, Lambert E, Hutson W, Iriarte LL, Imus HA: Amyotrophic lateral sclerosis in the Mariana Islands. AMA Arch Neurol Psychiatry 1956, 75:435-441
6. Reed D, Plato C, Elizan T, Kurland LT: The amyotrophic lateral sclerosis/parkinsonism-dementia complex: a ten-year follow-up on Guam. I. Epidemiologic studies. Am J Epidemiol 1966, 83:54-73
7. Reed DM, Brody JA: Amyotrophic lateral sclerosis and parkinsonism- dementia on Guam, 1945-1972. I. Descriptive epidemiology. Am J Epidemiol 1975, 101:287-301
8. Reed DM, Torres JM, Brody JA: Amyotrophic lateral sclerosis and parkinsonism-dementia on Guam, 1945-1972. II. Familial and genetic studies. Am J Epidemiol 1975, 101:302-310
9. Reed D, Labarthe D, Chen KM, Stallones R: A cohort study of amyotrophic lateral sclerosis and parkinsonism-dementia on Guam and Rota. Am J Epidemiol 1987, 125:92-100
10. Garruto RM, Yanagihara R, Gajdusek DC: Disappearance of high-incidence amyotrophic lateral sclerosis and parkinsonism-dementia on Guam. Neurology 1985, 35:193-198
11. Waring SC, Esteban-Santillan C, Reed DM, Craig UK, Labarthe DR, Petersen RC, Kurland LT: Incidence of amyotrophic lateral sclerosis and of the parkinsonism-dementia complex of Guam, 1950-1989. Neuroepidemiology 2004, 23:192-200
12. Wiederholt WC: Neuroepidemiologic research initiatives on Guam: past and present. Neuroepidemiology 1999, 18:279-291
13. Plato CC, Galasko D, Garruto RM, Plato M, Gamst A, Craig UK, Torres JM, Wiederholt W: ALS and PDC of Guam: forty-year follow-up. Neurology 2002, 58:765-773
14. Waring SC: Amyotrophic Lateral Sclerosis and Parkinsonism-Dementia Complex of Guam: Descriptive Epidemiology, Secular Trends, and Birth Cohort Effects on Incidence, 1950-1989, Ph.D. Thesis, School of Public Health, University of Texas Health Science Center, Houston, 1994
15. Galasko D, Salmon DP, Craig UK, Thal LJ, Schellenberg G, Wiederholt W: Clinical features and changing patterns of neurodegenerative disorders on Guam, 1997-2000. Neurology 2002, 58:90-97
16. Plato CC, Garruto RM, Galasko D, Craig UK, Plato M, Gamst A, Torres JM, Wiederholt W: Amyotrophic lateral sclerosis and parkinsonism-dementia complex of Guam: changing incidence rates during the past 60 years. Am J Epidemiol 2003, 157:149-157
17. Esclaire F, Kisby G, Spencer P, Milne J, Lesort M, Hugon J: The Guam cycad toxin methylazoxymethanol damages neuronal DNA and modulates tau mRNA expression and excitotoxicity. Exp Neurol 1999, 155:11-21
18. Garruto RM, Fukatsu R, Yanagihara R, Gajdusek DC, Hook G, Fiori CE: Imaging of calcium and aluminum in neurofibrillary tangle-bearing neurons in parkinsonism-dementia of Guam. Proc Natl Acad Sci USA 1984, 81:1875-1879
19. Hudson AJ, Rice GP: Similarities of Guamanian ALS/PD to post-encephalitic parkinsonism/ALS: possible viral cause. Can J Neurol Sci 1990, 17:427-433
20. Spencer PS, Nunn PB, Hugon J, Ludolph AC, Ross SM, Roy DN, Robertson RC: Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin. Science 1987, 237:517-522
21. Yanagihara R, Garruto RM, Gajdusek DC, Tomita A, Uchikawa T, Konagaya Y, Chen KM, Sobue I, Plato CC, Gibbs Jr CJ: Calcium and vitamin D metabolism in Guamanian Chamorros with amyotrophic lateral sclerosis and parkinsonism- dementia. Ann Neurol 1984, 15:42-48
22. Duncan MW: β-Methylamino-L-alanine (BMAA) and amyotrophic lateral sclerosis-parkinsonism dementia of the western Pacific. Ann NY Acad Sci 1992, 648:161-168
23. Montine TJ, Li K, Perl DP, Galasko D: Lack of β-methylamino-L- alanine in brain from controls, AD, or Chamorros with PDC. Neurology 2005, 65:768-769
24. Steele JC: Parkinsonism-dementia complex of Guam. Mov Disord 2005, 20(Suppl 12):S99-S107
25. Poorkaj P, Tsuang D, Wijsman E, Steinbart E, Garruto RM, Craig UK, Chapman NH, Anderson L, Bird TD, Plato CC, Perl DP, Weiderholt W, Galasko D, Schellenberg GD: TAU as a susceptibility gene for amyotropic lateral sclerosis-parkinsonism dementia complex of Guam. Arch Neurol 2001, 58:1871-1878
26. Sundar PD, Yu CE, Sieh W, Steinbart E, Garruto RM, Oyanagi K, Craig UK, Bird TD, Wijsman E, Galasko DR, Schellenberg GD: Two sites in the MAPT region confer genetic risk for Guam ALS/PDC and dementia. Hum Mol Genet 2007, 16:295-306
27. Morris HR, Steele JC, Crook R, Wavrant-De Vrieze F, Onstead-Cardinale L, Gwinn-Hardy K, Wood NW, Farrer M, Lees AJ, McGeer PL, Siddique T, Hardy J, Perez-Tur J: Genome-wide analysis of the parkinsonism-dementia complex of Guam. Arch Neurol 2004, 61:1889-1897
28. Wong CW, Quaranta V, Glenner GG: Neuritic plaques and cerebrovascular amyloid in Alzheimer disease are antigenically related. Proc Natl Acad Sci USA 1985, 82:8729-8732
29. Lee VM, Balin BJ, Otvos Jr L, Trojanowski JQ: A68: a major subunit of paired helical filaments and derivatized forms of normal tau. Science 1991, 251:675-678
30. Glenner GG, Wong CW: Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 1984, 120:885-890
31. Lee VM, Wang J, Trojanowski JQ: Purification of paired helical filament tau and normal tau from human brain tissue. Methods Enzymol 1999, 309:81-89
32. Tsuang DW, Bird TD: Genetics of dementia. Med Clin North Am 2002, 86:591-614
33. Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS: Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996, 47:1-9
34. McKeith I, Galasko D, Kosaka K, Perry E, Dickson D, Hansen L, Salmon D, Lowe J, Mirra S, Byrne E, Lennox G, Quinn N, Edwardson J, Ince P, Bergeron C, Burns A, Miller B, Lovestone S, Collerton D, Jansen E, Ballard C, de Vos R, Wilcock G, Jellinger K, Perry R: Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. Neurology 1996, 47:1113-1124
35. The National Institute on Aging and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease: Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol Aging 1997, 18:S1-S2
36. Braak H, Braak E: Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 1991, 82:239-259
37. Perl DP, Hof PR, Purohit DP, Loerzel AJ, Kakulas BA: Hippocampal and entorhinal cortex neurofibrillary tangle formation in Guamanian Chamorros free of overt neurologic dysfunction. J Neuropathol Exp Neurol 2003, 62:381-388
38. Mirra S, Heyman A, McKeel D, Sumi S, Crain B, Brownlee L, Vogel F, Hughes J, van Belle G, Berg L: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991, 41:479-486
39. Jakes R, Crowther RA, Lee VM, Trojanowski JQ, Iwatsubo T, Goedert M: Epitope mapping of LB509, a monoclonal antibody directed against human α-synuclein. Neurosci Lett 1999, 269:13-16
40. Leverenz JB, Fishel MA, Peskind ER, Montine TJ, Nochlin D, Steinbart E, Raskind MA, Schellenberg GD, Bird TD, Tsuang D: Lewy body pathology in familial Alzheimer disease - evidence for disease- and mutation-specific pathologic phenotype. Arch Neurol 2006, 63:370-376
41. Woltjer RL, Cimino PJ, Boutte AM, Schantz AM, Montine KS, Larson EB, Bird T, Quinn JF, Zhang J, Montine TJ: Proteomic determination of widespread detergent-insolubility including Aβ but not tau early in the pathogenesis of Alzheimer's disease. FASEB J 2005, 19:1923-1925
42. Harlow E, Lane D: Antibodies. A Laboratory Manual. Cold Spring Harbor, Cold Spring Harbor Laboratory Press, 1988
43. Kayed R, Sokolov Y, Edmonds B, Mclntire TM, Milton SC, Hall JE, Glabe CG: Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases. J Biol Chem 2004, 279:46363-46366
44. Weatherly DB, Astwood III JA, Minning TA, Cavola C, Tarleton RL, Orlando R: A heuristic method for assigning a false-discovery rate for protein identifications from mascot database search results. Mol Cell Proteomics 2005, 4:762-772
45. Kapp EA, Schutz F, Connolly LM, Chakel JA, Meza JE, Miller CA, Fenyo D, Eng JK, Adkins JN, Omenn GS, Simpson RJ: An evaluation, comparison, and accurate benchmarking of several publicly available MS/MS search algorithms: sensitivity and specificity analysis. Proteomics 2005, 5:3475-3490
46. Goedert M, Hasegawa M: The tauopathies: toward an experimental animal model. Am J Pathol 1999, 154:1-6
47. Campion D, Martin C, Heilig R, Charbonnier F, Moreau V, Flaman JM, Petit JL, Hannequin D, Brice A, Frebourg T: The NACP/synuclein gene - chromosomal assignment and screening for alterations in Alzheimer's disease. Genomics 1995, 26:254-257
48. Uéda K, Saitoh T, Mori H: Tissue-dependent alternative splicing of messenger-RNA for NACP, the precursor of non-A-β component of Alzheimer's disease amyloid. Biochem Biophys Res Commun 1994, 205:1366-1372
49. Lesné S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, Gallagher M, Ashe KH: A specific amyloid-β protein assembly in the brain impairs memory. Nature 2006, 440:352-357
50. Gong Y, Chang L, Viola KL, Lacor PN, Lambert MP, Finch CE, Krafft GA, Klein WL: Alzheimer's disease-affected brain: presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc Natl Acad Sci USA 2003, 100:10417-10422
51. Li Y, Nowotny P, Holmans P, Smemo S, Kauwe JS, Hinrichs AL, Tacey K, Doil L, van Luohene R, Garcia V, Rowland C, Schrodi S, Leong D, Gogic G, Chan J, Cravchik A, Ross D, Lau K, Kwok S, Chang SY, Catanese J, Sninsky J, White TJ, Hardy J, Powell J, Lovestone S, Morris JC, Thal L, Owen M, Williams J, Goate A, Grupe A: Association of late-onset Alzheimer's disease with genetic variation in multiple members of the GAPD gene family. Proc Natl Acad Sci USA 2004, 101:15688-15693
52. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, McCluskey LF, Miller BL, Masliah E, Mackenzie IR, Feldman H, Feiden W, Kretzschmar HA, Trojanowski JQ, Lee VM: Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006, 314:130-133
53. Skovronsky DM, Lee VM, Trojanowski JQ: Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications. Annu Rev Pathol Mech Dis 2006, 1:151-170
54. Yamazaki M, Arai Y, Baba M, Iwatsubo T, Mori O, Katayama Y, Oyanagi K: α-Synuclein inclusions in amygdala in the brains of patients with the parkinsonism-dementia complex of Guam. J Neuropathol Exp Neurol 2000, 59:585-591
55. Forman MS, Schmidt ML, Kasturi S, Perl DP, Lee VM, Trojanowski JQ: Tau and α-synuclein pathology in amygdala of parkinsonism-dementia complex patients of Guam. Am J Pathol 2002, 160:1725-1731
56. Sebeo J, Hof PR, Perl DP: Occurrence of α-synuclein pathology in the cerebellum of Guamanian patients with parkinsonism-dementia complex. Acta Neuropathol (Berl) 2004, 107:497-503
57. Jensen PH, Hager H, Nielsen MS, Hojrup P, Gliemann J, Jakes R: α-Synuclein binds to tau and stimulates the protein kinase A-catalyzed tau phosphorylation of serine residues 262 and 356. J Biol Chem 1999, 274:25481-25489
58. Zhukareva V, Joyce S, Schuck T, Van Deerlin V, Hurtig H, Albin R, Gilman S, Chin S, Miller B, Trojanowski JQ, Lee VM: Unexpected abundance of pathological tau in progressive supranuclear palsy white matter. Ann Neurol 2006, 60:335-345